These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18754513)

  • 1. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments.
    Gunnarsson L; Jauhiainen A; Kristiansson E; Nerman O; Larsson DG
    Environ Sci Technol; 2008 Aug; 42(15):5807-13. PubMed ID: 18754513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology beyond the patient - The environmental risks of human drugs.
    Gunnarsson L; Snape JR; Verbruggen B; Owen SF; Kristiansson E; Margiotta-Casaluci L; Österlund T; Hutchinson K; Leverett D; Marks B; Tyler CR
    Environ Int; 2019 Aug; 129():320-332. PubMed ID: 31150974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking: a potential tool to aid ecotoxicity testing in environmental risk assessment of pharmaceuticals.
    Walker SD; McEldowney S
    Chemosphere; 2013 Nov; 93(10):2568-77. PubMed ID: 24344392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental risk assessment of pharmaceutical drug substances--conceptual considerations.
    Länge R; Dietrich D
    Toxicol Lett; 2002 May; 131(1-2):97-104. PubMed ID: 11988362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aquatic plants exposed to pharmaceuticals: effects and risks.
    Brain RA; Hanson ML; Solomon KR; Brooks BW
    Rev Environ Contam Toxicol; 2008; 192():67-115. PubMed ID: 18020304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of ecotoxicity and mechanism of engineered nanoparticles to aquatic organisms].
    Wang ZY; Zhao J; Li N; Li FM; Xing BS
    Huan Jing Ke Xue; 2010 Jun; 31(6):1409-18. PubMed ID: 20698250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of the small cyclopoid copepod Paracyclopina nana as an invertebrate model for ecotoxicity testing.
    Dahms HU; Won EJ; Kim HS; Han J; Park HG; Souissi S; Raisuddin S; Lee JS
    Aquat Toxicol; 2016 Nov; 180():282-294. PubMed ID: 27770640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are pharmaceuticals with evolutionary conserved molecular drug targets more potent to cause toxic effects in non-target organisms?
    Furuhagen S; Fuchs A; Lundström Belleza E; Breitholtz M; Gorokhova E
    PLoS One; 2014; 9(8):e105028. PubMed ID: 25140792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the potential of the microbial assay for risk assessment (MARA) for ecotoxicological testing.
    Fai PB; Grant A
    Ecotoxicology; 2010 Nov; 19(8):1626-33. PubMed ID: 20882341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic activity of drugs and ecotoxicology--can the two be connected?
    Seiler JP
    Toxicol Lett; 2002 May; 131(1-2):105-15. PubMed ID: 11988363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.
    Arnold KE; Brown AR; Ankley GT; Sumpter JP
    Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating exposure into aquatic toxicological studies: an imperative.
    Wang WX
    Aquat Toxicol; 2011 Oct; 105(3-4 Suppl):9-15. PubMed ID: 22099340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecotoxicity evaluation of selected sulfonamides.
    Białk-Bielińska A; Stolte S; Arning J; Uebers U; Böschen A; Stepnowski P; Matzke M
    Chemosphere; 2011 Oct; 85(6):928-33. PubMed ID: 21752420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic toxicity of an environmentally relevant mixture of pharmaceuticals to three aquatic organisms (alga, daphnid, and fish).
    Watanabe H; Tamura I; Abe R; Takanobu H; Nakamura A; Suzuki T; Hirose A; Nishimura T; Tatarazako N
    Environ Toxicol Chem; 2016 Apr; 35(4):996-1006. PubMed ID: 26472177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioconcentration, bioaccumulation, and metabolism of pesticides in aquatic organisms.
    Katagi T
    Rev Environ Contam Toxicol; 2010; 204():1-132. PubMed ID: 19957234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization.
    Schmitt H; Boucard T; Garric J; Jensen J; Parrott J; Péry A; Römbke J; Straub JO; Hutchinson TH; Sánchez-Argüello P; Wennmalm A; Duis K
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():588-602. PubMed ID: 19958048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering pesticides according to their molecular properties, fate, and effects by considering additional ecotoxicological parameters in the TyPol method.
    Traoré H; Crouzet O; Mamy L; Sireyjol C; Rossard V; Servien R; Latrille E; Martin-Laurent F; Patureau D; Benoit P
    Environ Sci Pollut Res Int; 2018 Feb; 25(5):4728-4738. PubMed ID: 29197062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted critical environmental concentrations for 500 pharmaceuticals.
    Fick J; Lindberg RH; Tysklind M; Larsson DG
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):516-23. PubMed ID: 20816909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The water-soluble fraction of potentially toxic elements in contaminated soils: relationships between ecotoxicity, solubility and geochemical reactivity.
    Rocha L; Rodrigues SM; Lopes I; Soares AM; Duarte AC; Pereira E
    Chemosphere; 2011 Sep; 84(10):1495-505. PubMed ID: 21546051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.
    Groh KJ; Carvalho RN; Chipman JK; Denslow ND; Halder M; Murphy CA; Roelofs D; Rolaki A; Schirmer K; Watanabe KH
    Chemosphere; 2015 Feb; 120():764-77. PubMed ID: 25439131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.